Newton, MA, United States of America

James Patrick Jewell

USPTO Granted Patents = 21 

 

Average Co-Inventor Count = 8.6

ph-index = 6

Forward Citations = 136(Granted Patents)


Location History:

  • Jersey City, NJ (US) (2005 - 2010)
  • Sandwich, MA (US) (2009 - 2013)
  • Somerville, MA (US) (2013 - 2015)
  • Newtown, MA (US) (2016)
  • Newton, MA (US) (2019 - 2023)

Company Filing History:


Years Active: 2005-2023

Loading Chart...
Loading Chart...
21 patents (USPTO):

Title: Innovator Spotlight: James Patrick Jewell

Introduction: James Patrick Jewell is a prominent inventor based in Newton, MA, known for his significant contributions to the field of pharmaceutical innovations. With a remarkable portfolio of 21 patents, Jewell has made strides in developing compounds that have the potential to revolutionize treatments for various diseases.

Latest Patents: Among his latest innovations are the patents for Aza-benzothiophene compounds as STING agonists. These compounds, represented by a general formula (I), and their pharmaceutically acceptable salts, are designed to induce type I interferon production, particularly serving as STING active agents. His work provides new avenues for immune response induction and treatment of cell proliferation disorders, such as cancer. Additionally, he has developed oxo-tetrahydro-isoquinoline carboxylic acids as STING inhibitors, offering therapeutic potential for STING-mediated diseases, including inflammation, asthma, COPD, and cancer.

Career Highlights: Throughout his career, James Jewell has collaborated with major pharmaceutical organizations, most notably Merck Sharp & Dohme Corporation and Merck & Company, Inc. His work has not only elevated the understanding of STING pathway mechanisms but also contributed to developing targeted therapies for challenging health conditions.

Collaborations: Jewell's innovative journey has been enhanced through teamwork, notably with fellow researchers Michael D. Altman and Andrew M. Haidle. These collaborations have undoubtedly fostered the synergy necessary for pushing the boundaries of current scientific knowledge and technological advancements.

Conclusion: James Patrick Jewell continues to exemplify the spirit of innovation in the pharmaceutical industry. His pioneering patents and collaborations reflect a dedication to improving healthcare through scientific exploration. As he forges ahead, his work remains vital in developing effective treatments that address pressing medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…